Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study
Friedberg, Jonathan W, Cohen, Philip, Chen, Ling, Robinson, K Sue, Forero-Torres, Andres, La Casce, Ann S, Fayad, Luis E, Bessudo, Alberto, Camacho, Elber S, Williams, Michael E, van der Jagt, Richard H, Oliver, Jennifer W, Cheson, Bruce D
Published in Journal of clinical oncology (10.01.2008)
Published in Journal of clinical oncology (10.01.2008)
Get full text
Journal Article
Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma
Jagannath, Sundar, Durie, Brian G. M., Wolf, Jeffrey Lee, Camacho, Elber S., Irwin, David, Lutzky, Jose, McKinley, Marti, Potts, Phyllis, Gabayan, Afshin Eli, Mazumder, Amitabha, Crowley, John, Vescio, Robert
Published in British journal of haematology (01.09.2009)
Published in British journal of haematology (01.09.2009)
Get full text
Journal Article
A phase III, randomized, double-blind study of single-dose intravenous fosaprepitant in preventing chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy
Rapoport, Bernardo Leon, Weinstein, Cindy, Camacho, Elber S., Khanani, Saleem A., Beckford-Brathwaite, Elizabeth, Kevill, Lydia, Vallejos, Waldimir, Liang, Li Wen, Noga, Stephen Joseph
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A Multi-Center Phase 1b, Open-Label, Dose-Finding Pilot Study to Evaluate the Combination of Carfilzomib and Cyclophosphamide with Dexamethasone (CCyD) Prior to Autologous Stem Cell Transplant (ASCT) in Patients with Transplant Eligible Newly Diagnosed Multiple Myeloma
Bensinger, William I., Vescio, Robert, Gasparetto, Cristina, Camacho, Elber S., Nath, Rajneesh, Gomes, Christina L., Smith, David D., Shah, Jatin J., Durie, Brian G.M.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Phase III design for a trial of single-dose fosaprepitant (FA) in preventing chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC)
Noga, Stephen Joseph, Weinstein, Cindy, Camacho, Elber S, Khanani, Saleem A, Beckford-Brathwaite, Elizabeth, Vallejos, Waldimir, McGowan, Kelly, Tamburri, Grace, Force, Joanne, Taylor, Arlene
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A Phase II Study of Bortezomib (Velcade®), Cyclophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma
Bensinger, William, Jagannath, Sundar, Vescio, Robert, Camacho, Elber S., Wolf, Jeffrey Lee, Irwin, David H, Capo, Gerardo, McKinley, Marti, Potts, Phyllis, Vesole, David H., Mazumder, Amitabha, Esseltine, Dixie-Lee, Becker, Pamela, Crowley, John, Durie, Brian GM
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma : Results From a Phase II Multicenter, Single-Agent Study Authors'reply
FRIEDBERG, Jonathan W, COHEN, Philip, VAN DER JAGT, Richard H, OLIVER, Jennifer W, CHESON, Bruce D, LING CHEN, ROBINSON, K. Sue, FORERO-TORRES, Andres, LA CASCE, Ann S, FAYAD, Luis E, BESSUDO, Alberto, CAMACHO, Elber S, WILLIAMS, Michael E
Published in Journal of clinical oncology (2008)
Get full text
Published in Journal of clinical oncology (2008)
Journal Article
Long-Term Follow-Up of Patients Treated with Bortezomib Alone and in Combination with Dexamethasone as Frontline Therapy for Multiple Myeloma
Jagannath, Sundar, Durie, Brian G.M., Wolf, Jeffrey Lee, Camacho, Elber S., Irwin, David, Lutzky, Jose, McKinley, Marti, Gabayan, Afshin Eli, Mazumder, Amitabha, Crowley, John, Vescio, Robert
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Bendamustine HCl (TREANDATM) Treatment Results in High Rates of Objective Response in Patients with Rituximab-Refractory and Alkylator-Refractory Indolent B-Cell Non-Hodgkin's Lymphoma (NHL): Results from a Phase II Multicenter Single-Agent Study (SDX-105-01)
Friedberg, Jonathan W., Cohen, Philip, Cheson, Bruce D., Robinson, K. Sue, Forero-Torres, Andres, Fayad, Luis, La Casce, Ann S., Bessudo, Alberto, Camacho, Elber S., Williams, Michael E., van der Jagt, Richard H., Oliver, Jennifer, Benaim, Ely
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
DNCB reactivity and prognosis in 419 patients with malignant melanoma
Camacho, Elber S., Pinsky, Carl M., Braun, David W., Golbey, Robert B., Fortner, Joseph G., Wanebo, Harold J., Oettgen, Herbert F.
Published in Cancer (15.05.1981)
Published in Cancer (15.05.1981)
Get full text
Journal Article